{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:30:53Z","timestamp":1786995053450,"version":"build-2736575974"},"reference-count":15,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,5,30]],"date-time":"2020-05-30T00:00:00Z","timestamp":1590796800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurolog\u00eda"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.nrl.2020.05.009","type":"journal-article","created":{"date-parts":[[2020,7,14]],"date-time":"2020-07-14T01:49:22Z","timestamp":1594691362000},"page":"250-252","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["S\u00edndrome de opsoclono-mioclono secundario a intoxicaci\u00f3n por duloxetina"],"prefix":"10.1016","volume":"36","author":[{"given":"J.","family":"Trigo L\u00f3pez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Mart\u00ednez P\u00edas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Carrancho Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.I.","family":"Pedraza Hueso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nrl.2020.05.009_bib0080","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.ejpn.2009.03.002","article-title":"A prospective study of the presentation and management of dancing eye syndrome\/opsoclonus-myoclonus syndrome in the United Kingdom","volume":"14","author":"Pang","year":"2010","journal-title":"Eur J Paediatr Neurol"},{"key":"10.1016\/j.nrl.2020.05.009_bib0085","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/WCO.0b013e3280126b51","article-title":"An uptdate on opsoclonus","volume":"20","author":"Wong","year":"2007","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.nrl.2020.05.009_bib0090","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1097\/MOP.0b013e32833fde3f","article-title":"Update on diagnosis, treatment, and prognosis in opsoclonus-myoclonus-ataxia syndrome","volume":"22","author":"Gorman","year":"2010","journal-title":"Curr Opin Pediatr"},{"key":"10.1016\/j.nrl.2020.05.009_bib0095","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1001\/archneurol.2012.1173","article-title":"Adult-onset opsoclonus-myoclonus syndrome","volume":"69","author":"Klaas","year":"2012","journal-title":"Arch Neurol"},{"key":"10.1016\/j.nrl.2020.05.009_bib0100","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/ana.410060128","article-title":"Opsoclonus with amitriptyline overdose","volume":"6","author":"Au","year":"1979","journal-title":"Ann Neurol."},{"key":"10.1016\/j.nrl.2020.05.009_bib0105","first-page":"60","article-title":"Opsoclonus, a rare complicaci\u00f3n of cocaine misuse","author":"Elkadoudi-Pijnenburg","year":"1996","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.nrl.2020.05.009_bib0110","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1001\/jama.1974.03240090023018","article-title":"Lithium carbonate, haloperidol, and irreversible brain damage","volume":"230","author":"Cohen","year":"1974","journal-title":"JAMA."},{"key":"10.1016\/j.nrl.2020.05.009_bib0115","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1002\/ana.410210220","article-title":"Opsoclonus induced by phenytoin and diazepam","volume":"21","author":"Dehaene","year":"1987","journal-title":"Ann Neurol"},{"key":"10.1016\/j.nrl.2020.05.009_bib0120","first-page":"155","article-title":"Ocular flutter","volume":"10","author":"Fisher","year":"1990","journal-title":"J Clin Neuroophtalmol"},{"key":"10.1016\/j.nrl.2020.05.009_bib0125","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1080\/15563650.2017.1375511","article-title":"Opsoclonus-myoclonus syndrome following long-term use of cyclosporine","volume":"56","author":"Kang","year":"2018","journal-title":"Clin Toxicol (Phila)"},{"key":"10.1016\/j.nrl.2020.05.009_bib0130","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1097\/CJI.0000000000000228","article-title":"Ipilimumab\/Nivolumab-related Opsoclonus-Myoclonus-Ataxia Syndrome Variant in a Patient with Malignant Pleural Mesothelioma","volume":"41","author":"Maller","year":"2018","journal-title":"J Immunother"},{"key":"10.1016\/j.nrl.2020.05.009_bib0135","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jns.2018.10.028","article-title":"Opsoclonus-myoclonus-encephalopathy induced by cefepime","volume":"396","author":"Lizarraga","year":"2019","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.nrl.2020.05.009_bib0140","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jns.2016.11.023","article-title":"Opsoclonus-myoclonus ataxia syndrome secondary to venlafaxine intoxication","volume":"372","author":"Necp\u00e1l","year":"2017","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.nrl.2020.05.009_bib0145","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1212\/01.WNL.0000073271.66866.51","article-title":"Cerebellar activation in opsoclonus: An fMRI study","volume":"61","author":"Helmchen","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.nrl.2020.05.009_bib0150","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1097\/00002826-199206000-00002","article-title":"The neurobiology of the opsoclonus-myoclonus syndrome","volume":"15","author":"Pranzatelli","year":"1992","journal-title":"Clin Neuropharmacol"}],"container-title":["Neurolog\u00eda"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0213485320301328?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0213485320301328?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T13:11:59Z","timestamp":1759324319000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0213485320301328"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":15,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["S0213485320301328"],"URL":"https:\/\/doi.org\/10.1016\/j.nrl.2020.05.009","relation":{},"ISSN":["0213-4853"],"issn-type":[{"value":"0213-4853","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"S\u00edndrome de opsoclono-mioclono secundario a intoxicaci\u00f3n por duloxetina","name":"articletitle","label":"Article Title"},{"value":"Neurolog\u00eda","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nrl.2020.05.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Sociedad Espa\u00f1ola de Neurolog\u00eda. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}